Study Group For 25 High-Risk Items In August, Law Reform In Sight
This article was originally published in PharmAsia News
After the Japanese government decided to lift the ban on Internet generic drug sales, MHLW has decided to set up a study group in August to decide how to sell 25 drugs considered as high risk items, stated Pharmaceutical and Food Director Toshio Imabeppu in his first specialist paper since taking office.
You may also be interested in...
TransEnterix hires Shameze Rampertab as its new CFO and said it expects “modest growth” in Q3 and Q4.
Keeping Track: Viltepso Earns Priority Review Voucher; Manufacturing Trips Fennec; Eagle Drops Ryanodex Exertional Heat Stroke Bid
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
CureVac raised hundreds of millions of dollars this year before its $213m initial public offering as its mRNA vaccine technology moved into the COVID-19 spotlight. Its stock price tripled on its debut.